These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5162714)

  • 21. Symptomatic, radiological, and functional improvement following treatment of urinary schistosomiasis in Egypt.
    Farid Z; Bassily S; McConnell E; Schulert A; Sabour M; Abdel Wahab MF
    Lancet; 1967 Nov; 2(7526):1110-3. PubMed ID: 4168554
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral tracer sodium antimony-2, 3-meso-dimercapto-succinate (Astiban) in hamsters infected with Schistosoma mansoni.
    Girgis GR; Girgis NI; Schulert AR; McConnell E
    J Egypt Public Health Assoc; 1966; 41(4):237-42. PubMed ID: 6002838
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of urinary bilharziasis in a small focus with sodium antimony dimercaptosuccinate (astiban).
    Arfaa F; Tohidi E; Ardelan A
    Am J Trop Med Hyg; 1967 May; 16(3):300-3. PubMed ID: 6023686
    [No Abstract]   [Full Text] [Related]  

  • 24. [Value of the MMEF/FEV1 index for the interpretation of spirographic data and the diagnosis of ventilatory disorders of the obstructive type].
    Szafrański W
    Pneumonol Pol; 1983 May; 51(5):265-75. PubMed ID: 6622270
    [No Abstract]   [Full Text] [Related]  

  • 25. Preliminary report on some clinical and biochemical observations in patients treated with Bilharcid.
    Faríd F; Moussà AH; Abulfadl AM; El-Raziky EH; Adham I
    Egypt J Bilharz; 1975; 2(1):31-6. PubMed ID: 810341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intramedullary spinal cord schistosomiasis: case report.
    Odeku EL; Lucas AO; Richard DR
    J Neurosurg; 1968 Oct; 29(4):418-23. PubMed ID: 5699505
    [No Abstract]   [Full Text] [Related]  

  • 27. [Maximum expiratory flow rate (peak flow) in healthy persons and patients with bronchial asthma].
    Vargas FS; Cukier A; Terra Filho M; Croce J; Romeiro Neto MM
    Allergol Immunopathol (Madr); 1982; 10(2):91-4. PubMed ID: 6213139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressive management of urinary schistosomiasis with antimony dimercaptosuccinate (TWSb) in Ghana.
    Wolfe MS; Quansah FO; Agbemadzo F
    J Trop Med Hyg; 1966 Oct; 69(10):217-23. PubMed ID: 5929012
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic evaluation of antimony and sodium dimercaptosuccinate in the treatment of schistosomiasis mansoni].
    Siqueira MW; Huggins D
    Rev Bras Med; 1967 Feb; 24(2):97-9. PubMed ID: 5604907
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental and clinical studies with a new antimonial preparation for the treatment of schistosomiasis.
    Pedrique MR; Ercoli N
    Bull World Health Organ; 1971; 45(4):411-7. PubMed ID: 5317079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs for schistosomiasis.
    Drug Ther Bull; 1968 Aug; 6(18):70-2. PubMed ID: 5679475
    [No Abstract]   [Full Text] [Related]  

  • 32. The control of urinary schistosomiasis. Trials of niridazole and other drugs in children attending primary schools in Zanzibar, Tanzania, and the failure of a pilot eradication programme.
    Macdonald G; Forsyth DM; Rayski C; Rashid C
    Ann Trop Med Parasitol; 1968 Dec; 62(4):407-15. PubMed ID: 5729254
    [No Abstract]   [Full Text] [Related]  

  • 33. [Imported parasitic diseases: apropos of 4 cases of schistosomiasis].
    Fontaine J; Baillargeon J; Charron J; Panisset LC
    Union Med Can; 1971 May; 100(5):930-5. PubMed ID: 5163010
    [No Abstract]   [Full Text] [Related]  

  • 34. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials with oral oxamniquine (UK 4271) for the treatment of mansonian schistosomiasis.
    da Silva LC; Sette H; Chamone DA; Alquezar AS; Punskas JA; Raia S
    Rev Inst Med Trop Sao Paulo; 1974 Mar; 16(2):103-9. PubMed ID: 4845456
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical study on hepatosplenomegalic schistosomiasis japonica on Leyte Island: follow-up study 4 years after treatment with praziquantel.
    Hayashi M; Matsuda H; Tormis LC; Noseñas JS; Blas BL
    Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):498-501. PubMed ID: 6535265
    [No Abstract]   [Full Text] [Related]  

  • 37. Relationship between dyspnea, peak expiratory flow rate and wheeze in obstructive lung disease.
    Srisawai P
    J Med Assoc Thai; 1997 May; 80(5):319-25. PubMed ID: 9175376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of the chemotherapeutic index in the treatment of schistosomiasis with antimony compounds.
    Ercoli N
    Bull World Health Organ; 1971; 45(3):371-5. PubMed ID: 5316915
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of airway obstruction in recreational SCUBA divers.
    Weaver LK; Churchill SK; Hegewald MJ; Jensen RL; Crapo RO
    Wilderness Environ Med; 2009; 20(2):125-8. PubMed ID: 19594212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An epidemiological study of Schistosoma haematobium and S. mansoni infection in thirty-five rural Egyptian villages.
    Miller F; Hussein M; Mancy KH; Hilbert MS; Monto AS; Barakat RM
    Trop Geogr Med; 1981 Dec; 33(4):355-65. PubMed ID: 7342382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.